What is the recommended dosing regimen for Tb400 (thymosin beta-4) peptide in a typical adult patient with no significant medical history?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

TB-400 Peptide Dosing

For TB-400 (thymosin beta-4) peptide, administer 0.5 mL (15 drops) sublingually three times daily, holding under the tongue for 1-2 minutes before swallowing, with no food or drink for 10-15 minutes before and after each dose. 1

Administration Protocol

The FDA-approved sublingual route provides optimal bioavailability for this peptide formulation:

  • Dose: 0.5 mL or 15 drops per administration 1
  • Frequency: Three times daily 1
  • Technique: Hold under tongue for 1-2 minutes before swallowing to allow mucosal absorption 1
  • Fasting requirement: Avoid food or drink for 10-15 minutes before and after each dose to prevent interference with absorption 1

Rationale for Sublingual Delivery

Sublingual administration bypasses first-pass hepatic metabolism and addresses the inherent challenges of peptide delivery, including poor membrane permeability and instability in the gastrointestinal tract 2. This route is particularly advantageous for peptides like thymosin beta-4, which would otherwise require frequent parenteral injections 2.

Clinical Context

Thymosin beta-4 has demonstrated therapeutic potential in cardiac repair, wound healing, and tissue regeneration through multiple mechanisms including promotion of cell migration, survival, angiogenesis, and progenitor cell activation 3, 4, 5. The peptide has shown efficacy in improving cardiac function after myocardial infarction, enhancing dermal burn wound healing in diabetic models, and reactivating embryonic cardiac programs in adult tissue 3, 6, 5.

Important Considerations

Adherence to timing: The 10-15 minute fasting window before and after dosing is critical for maintaining consistent absorption and therapeutic levels 1. Patients should be counseled that food, beverages, or other oral medications during this window may significantly reduce bioavailability.

Dosing consistency: The three-times-daily regimen requires structured scheduling to maintain therapeutic peptide concentrations throughout the day 1. Unlike some peptide therapies with extended half-lives, this formulation necessitates frequent administration for sustained effect.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.